Stay updated on SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Sign up to get notified when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.

Latest updates to the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page
- Check4 days agoChange DetectedThe new screenshot shows minor visual and layout updates with no changes to core study information (title, conditions, eligibility criteria, or outcome measures).SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0), while removing the previous version tag (v3.1.0). The page now informs users about potential delays and where to check official status.SummaryDifference4%

- Check40 days agoChange DetectedUpdate: version bumped to v3.1.0 and new contact details added (email and phone). Removed: previous version label v3.0.2.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed. There are no substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.3%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a new version revision. However, several location-related details and specific disease resources have been removed.SummaryDifference2%

Stay in the know with updates to SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.